Eagle Capital Growth Quote - GRF

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

9.83

Bid

Offer

Volume

0.00 Day's Range 0.00

8.72 52 Week Range 11.24

Market Cap

39.004M

Previous Close

9.83

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

6,655

Shares Outstanding

3,967,836

Dividend Yield

6.92%

PE Ratio

8.46

Earnings Per Share (EPS)

1.16

Revenue

736k

Net Profit

4.61M

The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments.

Sector

Unit Inv Tr, Closed-end Mgmt

Industry

Unit Inv Tr, Closed-end Mgmt

Headquarters

Lutherville Timonium, Maryland, USA

Founded

Eagle Capital Growth Fund Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the American Stock Exchange with ticker GRF. The last closing price for Eagle Capital Growth was US$9.83. Over the last year, Eagle Capital Growth shares have traded in a share price range of US$ 8.72 to US$ 11.24.

Eagle Capital Growth currently has 3,967,836 shares in issue. The market capitalisation of Eagle Capital Growth is US$39 million. Eagle Capital Growth has a price to earnings ratio (PE ratio) of 8.46.

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

Form 4 - Statement of changes in beneficial ownership of securities

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

SAN CARLOS, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and...

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash

The Eagle Capital Growth Fund, Inc. (“Fund”) (NYSE American: GRF) today declared a year-end distribution of $0.68 per share in cash. The record date for this distribution is November 29, 2024...

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasisGrifols surgical bleeding management...

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur mustard, a chemical warfare...

Form 4 - Statement of changes in beneficial ownership of securities

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.28	-2.76953511375	10.11	10.28	9.51	1428	9.89695072	CS
4	-0.43	-4.1910331384	10.26	11.24	8.85	13094	9.93733491	CS
12	0.07	0.717213114754	9.76	11.24	8.85	6655	9.97999281	CS
26	0.3	3.14795383001	9.53	11.24	8.85	5047	9.82173426	CS
52	0.22	2.28928199792	9.61	11.24	8.72	3876	9.63521801	CS
156	0.09	0.924024640657	9.74	11.25	7.8	4671	9.17474499	CS
260	2.03	26.0256410256	7.8	11.25	5.2	4984	8.53878824	CS

GRF - Frequently Asked Questions (FAQ)

What is the current Eagle Capital Growth share price?

The current share price of Eagle Capital Growth is US$ 9.83

How many Eagle Capital Growth shares are in issue?

Eagle Capital Growth has 3,967,836 shares in issue

What is the market cap of Eagle Capital Growth?

The market capitalisation of Eagle Capital Growth is USD 39M

What is the 1 year trading range for Eagle Capital Growth share price?

Eagle Capital Growth has traded in the range of US$ 8.72 to US$ 11.24 during the past year

What is the PE ratio of Eagle Capital Growth?

The price to earnings ratio of Eagle Capital Growth is 8.46

What is the cash to sales ratio of Eagle Capital Growth?

The cash to sales ratio of Eagle Capital Growth is 52.99

What is the reporting currency for Eagle Capital Growth?

Eagle Capital Growth reports financial results in USD

What is the latest annual turnover for Eagle Capital Growth?

The latest annual turnover of Eagle Capital Growth is USD 736k

What is the latest annual profit for Eagle Capital Growth?

The latest annual profit of Eagle Capital Growth is USD 4.61M

What is the registered address of Eagle Capital Growth?

The registered address for Eagle Capital Growth is 2405 YORK ROAD, SUITE 201, LUTHERVILLE TIMONIUM, MARYLAND, 21093 2264

Which industry sector does Eagle Capital Growth operate in?

Eagle Capital Growth operates in the UNIT INV TR, CLOSED-END MGMT sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAPYKurv Yield Premium Strategy Apple AAPL ETF	US$ 27.35 (0.00%)	0
AAPXT Rex 2X Long Apple Daily Target ETF	US$ 32.80 (0.00%)	0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026	US$ 26.4077 (0.00%)	0
AAAUGoldman Sachs Physical Gold ETF Shares	US$ 25.77 (0.00%)	0
AAAAlternative Access First Priority CLO Bond ETF	US$ 25.11 (0.00%)	0
AAPYKurv Yield Premium Strategy Apple AAPL ETF	US$ 27.35 (0.00%)	0
AAPXT Rex 2X Long Apple Daily Target ETF	US$ 32.80 (0.00%)	0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026	US$ 26.4077 (0.00%)	0
AAAUGoldman Sachs Physical Gold ETF Shares	US$ 25.77 (0.00%)	0
AAAAlternative Access First Priority CLO Bond ETF	US$ 25.11 (0.00%)	0
AAPYKurv Yield Premium Strategy Apple AAPL ETF	US$ 27.35 (0.00%)	0
AAPXT Rex 2X Long Apple Daily Target ETF	US$ 32.80 (0.00%)	0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026	US$ 26.4077 (0.00%)	0
AAAUGoldman Sachs Physical Gold ETF Shares	US$ 25.77 (0.00%)	0
AAAAlternative Access First Priority CLO Bond ETF	US$ 25.11 (0.00%)	0